logo
episode-header-image
Aug 2022
14m 8s

Podcast 298: COPD exacerbations — 7 days...

NEJM Group
About this episode
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote […] 
Up next
Aug 2022
Podcast 301: Monkeypox — what to look for, how to treat
<p>A VIDEO RECORDING OF THIS INTERVIEW IS <a href='https://cdn.jwplayer.com/players/DQOIo47Q-rmTFgmxB.html'>AVAILABLE HERE</a>.</p> <p>This time, we look to New York for guidance on recognizing and treating monkeypox.</p> <p>Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum ... Show More
17m 28s
Aug 2022
Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
<p>A VIDEO RECORDING OF THIS INTERVIEW <a href='https://cdn.jwplayer.com/players/fEcmO0RQ-rmTFgmxB.html'>IS AVAILABLE HERE</a>.</p> <p>We’re back with another interview from this year’s IASLC conference.</p> <p>This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mar ... Show More
9m 32s
Aug 2022
Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
<p>A VIDEO RECORDING OF THIS INTERVIEW <a href='https://cdn.jwplayer.com/players/oTVn3trC-rmTFgmxB.html'>IS AVAILABLE HERE</a>.</p> <p>Interim results on overall survival in phase 3 of the IMpower010 trial were presented at this year’s meeting of the International Assosciation fo ... Show More
14m 58s
Recommended Episodes
Feb 2024
Outpatient Antibiotic Stewardship
<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p> <p>Guest: Kelsey L. Jensen, Pharm.D., R.Ph.</p> <p>Guest: Daniel Ilges, Pharm.D., R.Ph., BCIPD</p> <p>The appropriate use of antibiotics is important for a variety of reasons. It helps k ... Show More
23m 2s
Jun 2024
Antibiotikaresistenzen: Eine interdisziplinäre Herausforderung
Antibiotikaresistenzen: Vom richtigen Umgang mit Antibiotika bis Therapien der Zukunft 
32m 37s
May 2023
ASCO23: PALMIRA, LEONARDA-1, and Other Advances in Breast Cancer
<div class="OutlineElement Ltr SCXW250592669 BCX0"> <p class="Paragraph SCXW250592669 BCX0">Dr. Allison Zibelli and Dr. Megan Kruse highlight the PALMIRA and LEONARDA-1 trials, a new standard of care in the treatment of hand-foot syndrome for patients receiving capecitabine, and ... Show More
19m 49s
May 2024
Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer – CDK4/6 Inhibitors Rapid Update
Dr. Rachel Freedman and Dr. Sharon Giordano share the latest rapid guideline update from ASCO on the adjuvant use of the CDK4/6 inhibitors abemaciclib and ribociclib in patients with stage II and III breast cancer. They share details on the impetus for the update, supporting evid ... Show More
11m 23s
Feb 2024
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.3 Part 1
Dr. Jyoti Patel and Dr. Natasha Leighl discuss the latest full update to the stage IV NSCLC without driver alterations living guideline. This guideline addresses first-, second-, and subsequent-line therapy for patients according to their histology (squamous cell and nonsquamous ... Show More
9m 49s
May 2024
ASCO24: The Future of Personalized Immunotherapy
<p><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;"><span class="normaltextrun"> <span style= "line-height: 107%; color: black; background: white;">Dr. Diwakar Davar and Dr. Jason Luke discuss key abstracts from the 2024 ASCO Annual Meeting that explore ... Show More
34m 42s
Jun 2023
THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23
<div class="OutlineElement Ltr SCXW112417831 BCX0"> <p class="Paragraph SCXW112417831 BCX0"><span style= "font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;"> Drs. Rana McKay and Jonathan Rosen ... Show More
23m 25s
Apr 2023
VTE Prophylaxis and Treatment in Patients with Cancer Guideline Update
Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for VTE treatment in patients with cancer and evaluating direct factor Xa inhibitors ... Show More
14m 5s
Sep 2021
Dr Andrew Weil on How To Reduce Inflammation and Create Health #200
I’m kicking off this season of the podcast with a very special guest. Dr Andrew Weil is a pioneer in the field of integrative health and is the founder and Director of the University of Arizona’s Center for Integrative Medicine – where he’s also Clinical Professor of Medicine and ... Show More
1h 52m